Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients

References

• Abaci A, Oguzhan A, Kahraman S, et al. (1999). Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99:2239–42.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–53.
   PubMed Web of Science ®Google Scholar
• Al-Kafaji G, Al-Mahroos G, Alsayed NA, et al. (2015). Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes. Mol Med Rep 12:7485–90.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108:5003–8.
   PubMed Web of Science ®Google Scholar
• Bao Y, Ma X, Li H, et al. (2010). GlycatedhaemoglobinA1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. Diab Care 33:2184–9.
   PubMed Web of Science ®Google Scholar
• Baraniskin A, Kuhnhenn J, Schlegel U, et al. (2011). Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood 117:3140–6.
   PubMed Web of Science ®Google Scholar
• Bartel DP. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136:215–33.
   PubMed Web of Science ®Google Scholar
• Bash LD, Selvin E, Steffes M, et al. (2008). Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: atherosclerosis risk in communities (ARIC) study. Arch Intern Med 168:2440–7.
   PubMedGoogle Scholar
• Chen X, Ba Y, Ma L, et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997–1006.
   PubMed Web of Science ®Google Scholar
• Chen X, Liang H, Zhang J, et al. (2012). Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22:125–32.
   PubMed Web of Science ®Google Scholar
• Cicek G, Uyarel H, Ergelen M, et al. (2011). Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 22:131–7.
   PubMed Web of Science ®Google Scholar
• Cohen R, Snieder H, Lindsell C, et al. (2006). Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care 29:1739–43.
   PubMed Web of Science ®Google Scholar
• de Boer HC, van Solingen C, Prins J, et al. (2013). Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J 34:3451–7.
   PubMed Web of Science ®Google Scholar
• Etheridge A, Lee I, Hood L, et al. (2011). Extracellular microRNA: a new source of biomarkers. Mutat Res 717:85–90.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, et al. (2010). Circulating microRNAs in patients with coronary artery disease. Circ Res 107:677–84.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, Zeiher AM, Dimmeler S. (2011). Circulating microRNAs: biomarkers or mediators of cardiovascular diseases. Arterioscler Thromb Vasc Biol 31:2383–90.
   PubMed Web of Science ®Google Scholar
• Fish JE, Santoro MM, Morton SU, et al. (2008). miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15:272–84.
   PubMed Web of Science ®Google Scholar
• Flammer AJ, Anderson T, Celermajer DS, et al. (2012). The assessment of endothelial function: from research into clinical practice. Circulation 126:753–67.
   PubMed Web of Science ®Google Scholar
• Fukushima Y, Nakanishi M, Nonogi H, et al. (2011). Assessment of plasma miRNAs in congestive heart failure. Circ J 75:336–40.
   PubMed Web of Science ®Google Scholar
• Gallagher EJ, Le Roith D, Bloomgarden Z. (2009). Review of hemoglobin A(1c) in the management of diabetes. J Diabetes 1:9–17.
   PubMed Web of Science ®Google Scholar
• Geng Q, Fan T, Zhang B, et al. (2014). Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Respi Res 25:149.
   Web of Science ®Google Scholar
• Ghazanfari Z, Haghdoost AA, Alizadeh SM, et al. (2010). A comparison of HbA1c and fasting blood sugar tests in general population. Int J Prev Med 1:187–94.
   PubMedGoogle Scholar
• Grundy SM, Pasternak R, Greenland P, Jr SS, Fuster V. (1999). Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American heart association and the American college of cardiology. Circulation 100:1481–92.
   PubMed Web of Science ®Google Scholar
• Ha TY. (2011). MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw 11:135–54.
   PubMedGoogle Scholar
• Harris TA, Yamakuchi M, Kondo M, et al. (2010). Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells. Arterioscler Thromb Vasc Biol 30:1990–7.
   PubMed Web of Science ®Google Scholar
• Hausler SF, Keller A, Chandran PA, et al. (2010). Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 103:693–700.
   PubMed Web of Science ®Google Scholar
• Heishima K, Mori T, Ichikawa Y, et al. (2015). MicroRNA-214 and microRNA-126 are potential biomarkers for malignant endothelial proliferative diseases. Int J Mol Sci 16:25377–91.
   PubMed Web of Science ®Google Scholar
• Hernandez D, Espejo-Gil A, Bernal-Lopez MR, et al. (2013). Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population. BMC Nephrol 14:151.
   PubMed Web of Science ®Google Scholar
• Hinzmann R, Schlaeger C, Tran CT. (2012). What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes? Int J Med Sci 9:665–81.
   PubMed Web of Science ®Google Scholar
• Hong L, Li X, Guo Y, et al. (2014). Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina. Lipids Health Dis 13:89.
   PubMed Web of Science ®Google Scholar
• Howard BV, Robbins DC, Sievers ML, et al. (2000). LDL Cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL.The Strong heart study. Arterioscler Thromb Vasc Biol 20:830–5.
   PubMed Web of Science ®Google Scholar
• Hunter MP, Ismail N, Zhang X, et al. (2008). Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3:e3694.
   PubMed Web of Science ®Google Scholar
• Jansent F, Yang X, Proebsting S, et al. (2014). MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. A J Heart Assoc 3:e001249.
   Google Scholar
• Keller A, Leidinger P, Bauer A, et al. (2011). Toward the blood-borne miRNome of human diseases. Nat Methods 8:841–3.
   PubMed Web of Science ®Google Scholar
• Klipatrik ES. (2000). Glycatedhaemoglobin in the year 2000. J Clin Pathol 53:335–9.
   PubMed Web of Science ®Google Scholar
• Kloosterman WP, Plasterk RH. (2006). The diverse functions of microRNAs in animal development and disease. Dev Cell 11:441–50.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Yoshioka Y, et al. (2010). Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285:17442–52.
   PubMed Web of Science ®Google Scholar
• Laakso M. (2010). Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care 33:442–9.
   PubMed Web of Science ®Google Scholar
• Larsen ML, Hørder M, Mogensen EF. (1990). Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med 323:1021–5.
   PubMed Web of Science ®Google Scholar
• Laterza OF, Lim L, Garrett-Engele PW, et al. (2009). Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55:1977–83.
   PubMed Web of Science ®Google Scholar
• Latronico MV, Catalucci D, Condorelli G. (2007). Emerging role of microRNAs in cardiovascular biology. Circ Res 101:1225–36.
   PubMed Web of Science ®Google Scholar
• Lemesle G, Bonello L, De Labriolle A, et al. (2009). Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation. Am J Cardiol 104:41–5.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao G, Yang C, et al. (2014). The role of circulating microRNA-126 (miR-126): A novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci 15:10567–77.
   PubMed Web of Science ®Google Scholar
• Long G, Wang F, Duan Q, et al. (2012). Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci 8:811–18.
   PubMed Web of Science ®Google Scholar
• Luscher TF, Tanner FC, Tschudi MR, Noll G. (1993). Endothelial dysfunction in coronary artery disease. Annu Rev Med 44:395–418.
   PubMed Web of Science ®Google Scholar
• McDonald JS, Milosevic D, Reddi HV, et al. (2010). Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57:833–40.
   Web of Science ®Google Scholar
• Meder B, Keller A, Vogel B, et al. (2011). MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 106:13–23.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513–18.
   PubMed Web of Science ®Google Scholar
• Nathan DM. (1993). Long-term complications of diabetes mellitus. N Engl J Med 328:1676–85.
   PubMed Web of Science ®Google Scholar
• Ortega FJ, Mercader JM, Moreno-Navarrete JM, et al. (2014). Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diab Care 37:1375–83.
   PubMed Web of Science ®Google Scholar
• Pillai RS, Bhattacharyya SN, Filipowicz W. (2007). Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17:118–26.
   PubMed Web of Science ®Google Scholar
• Pinelli N, Jantz A, Martin E, Jaber L. (2011). Sensitivity and specificity of gly-cated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 96:E1680–3.
   Web of Science ®Google Scholar
• Poy MN, Hausser J, Trajkovski M, et al. (2009). miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci USA 106:5813–18.
   PubMed Web of Science ®Google Scholar
• Rajendran P, Rengarajan T, Thangavel J, et al. (1993). The vascular endothelium and human diseases. Int J Biol Sci 9:1057–69.
   Web of Science ®Google Scholar
• Rawal S, Manning P, Katare R. (2014). Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease. Cardiovasc Diabeto 13:44.
   PubMed Web of Science ®Google Scholar
• Roberts WL, De BK, Brown D, et al. (2002). Effects of hemoglobin C and S traits on eight glycohemoglobin methods. Clin Chem 48:383–5.
   PubMed Web of Science ®Google Scholar
• Roggli E, Britan A, Gattesco S, et al. (2010). Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59:978–86.
   PubMed Web of Science ®Google Scholar
• Roth P, Wischhusen J, Happold C, et al. (2011). A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 118:449–57.
   PubMed Web of Science ®Google Scholar
• Rykova EY, Wunsche W, Brizgunova OE, et al. (2006). Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods. Ann N Y Acad Sci 1075:328–33.
   PubMed Web of Science ®Google Scholar
• Sato Y. (2001). Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct Funct 26:19–24.
   PubMed Web of Science ®Google Scholar
• Schrauder MG, Strick R, Schulz-Wendtland R, et al. (2012). Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 7:e29770.
   PubMed Web of Science ®Google Scholar
• Selvin E, Marinopoulos S, Berkenblit G, et al. (2004). Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421–31.
   PubMed Web of Science ®Google Scholar
• Selvin E, Steffes MW, Zhu H, et al. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800–11.
   PubMed Web of Science ®Google Scholar
• Shah AD, Nicholas O, Timmis AD, et al. (2011). Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis. PLoS Med 8:e1000439.
   Google Scholar
• Small EM, Frost RJA, Olson EN. (2010). MicroRNAs add a new dimension to cardiovascular disease. Circulation 121:1022–32.
   PubMed Web of Science ®Google Scholar
• Sun X, Zhang M, Sanagawa A, et al. (2012). Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb J 10:16.
   PubMedGoogle Scholar
• Tijsen AJ, Pinto YM, Creemers EE. (2012). Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 303:H1085–95.
   PubMed Web of Science ®Google Scholar
• Timmer JR, Hoekstra M, Nijsten MW, et al. (2011). Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 124:704–11.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, et al. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–9.
   PubMed Web of Science ®Google Scholar
• van Sloten TT, Henry RM, Dekker JM, et al. (2014). Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study. Hypertension 64:1299–305.
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. (2011). MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13:423–33.
   PubMed Web of Science ®Google Scholar
• Waden J, Forsblom C, Thorn LM, et al. (2009). A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes 58:2649–55.
   PubMed Web of Science ®Google Scholar
• Wang S, Aurora AB, Johnson BA, et al. (2008). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15:261–71.
   PubMed Web of Science ®Google Scholar
• Whiting DR, Guariguata L, Weil C, Shaw J. (2011). IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–21.
   PubMed Web of Science ®Google Scholar
• Widmer RJ, Chung W, Herrmann J, et al. (2014). The association between circulating microRNA levels and coronary endothelial function. PLoS One 9:e109650.
   PubMed Web of Science ®Google Scholar
• Wong L, Lee K, Russell I, Chen C. (2007). Endogenous controls for real time quantitation of miRNA using TaqMan® MicroRNA assays. New York: Macmillan Publishers Ltd.
   Google Scholar
• Yu XY, Chen JY, Zheng ZW, et al. (2013). Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention. Eurointervention 9:546–54.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Kiechl S, Drozdov I, et al. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810–17.
   PubMed Web of Science ®Google Scholar
• Zernecke A, Bidzhekov K, Noels H, et al. (2010). Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2:ra81.
   Web of Science ®Google Scholar
• Zhang Q, Kandic I, Kutryk MJ. (2011). Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochem Biophys Res Commun 405:42–6.
   PubMed Web of Science ®Google Scholar
• Zhang T, Lv C, Li L, et al. (2013). Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. Biomed Res Int 2013:761617.
   PubMed Web of Science ®Google Scholar
• Zhao CH, Cheng GC, He RL, et al. (2015). Analysis and clinical significance of microRNA-499 expression levels in serum of patients with acute myocardial infarction. Gent Mol Res 14:4027–34.
   PubMed Web of Science ®Google Scholar
• Zhao C, Dong J, Jiang T, et al. (2011). Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS One 6:e23925.
   PubMed Web of Science ®Google Scholar
• Zheng D, Haddadin S, Wang Y, et al. (2011). Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol 4:575–86.
   PubMed Web of Science ®Google Scholar